ARCHIVES

House subcommittee’s 5.6% Increase For NIH includes $2.5 Billion for NCI

This article is from The Cancer Letter archive.

Vol. 23 No. 28 | July 18, 1997

Download PDF Visit The Full Archive

Related Articles

Wistar’s Koprowski; Rivera Is Director

April 12, 1991

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

White House Okays Committee ‘Kill’ Lists; Workshops To Plan Projects In Carcinogenesis

July 22, 1977

High Dose Chemotherapy Significantly Prolongs Survival In ECOG Clinical Trial

November 28, 2008

Charges Against CC Probed; Most Found Invalid

March 31, 1978

Community-Based Program Final Planning Review In August, October

August 6, 1976